Strong association of the APOA5-1131T>C gene variant and early-onset acute myocardial infarction

Atherosclerosis

Volumn 214, Issue 2, 2011, Pages 397-403

  De Caterina, Raffaele ^a   Talmud, Philippa J ^b   Merlini, Piera Angelica ^c   Foco, Luisa ^d   Pastorino, Roberta ^d   Altshuler, David ^e,f   Mauri, Francesco ^c   Peyvandi, Flora ^g   Lina, Daniela ^h   Kathiresan, Sekar ^e,i   Bernardinelli, Luisa ^d   Ardissino, Diego ^h  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF MILAN   (Italy)

^h UNIVERSITY HOSPITAL OF PARMA   (Italy)

ⁱ HARVARD UNIVERSITY   (United States)

Author keywords

APOA5 1131T>C gene variant; Association studies; Genetics; Myocardial infarction; Single nucleotide polymorphisms

Indexed keywords

ADIPONECTIN; ALOX5AP PROTEIN; APOLIPOPROTEIN A5; CD31 ANTIGEN; CHOLESTEROL; COCAINE; INTERLEUKIN 6; LIPOPROTEIN LIPASE; PHOSPHOLIPASE A2 GROUP II; PLA2G7 PROTEIN; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; EARLY ONSET MYOCARDIAL INFARCTION; EXERCISE; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE OF ONSET; APOLIPOPROTEINS A; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MYOCARDIAL INFARCTION; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; TRIGLYCERIDES; UP-REGULATION;

EID: 79151483367     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.11.011     Document Type: Article

References (40)

1. Kathiresan S., Voight B.F., Purcell S., et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009, 41:334-341.
2. Samani N.J., Deloukas P., Erdmann J., et al. Large scale association analysis of novel genetic loci for coronary artery disease. Arterioscler Thromb Vasc Biol 2009, 29:774-780.
3. Zdravkovic S., Wienke A., Pedersen N.L., et al. Heritability of death from coronary heart disease: a 36-year follow-up of 20,966 Swedish twins. J Intern Med 2002, 252:247-254.
4. Atherosclerosis Thrombosis and Vascular Biology Italian Study Group. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation. 2003, 107:1117-22.
5. Olivier M., Wang X., Cole R., et al. Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Genomics 2004, 83:912-923.
6. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996, 3:213-219.
7. Sarwar N., Sandhu M.S., Ricketts S.L., et al. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 2010, 375:1634-1639.
8. Wootton P.T., Drenos F., Cooper J.A., et al. Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study. Hum Mol Genet 2006, 15:355-361.
9. Mallat Z., Benessiano J., Simon T., et al. Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study. Arterioscler Thromb Vasc Biol 2007, 27:1177-1183.
10. Hegener H.H., Lee I.M., Cook N.R., Ridker P.M., Zee R.Y. Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: a nested case-control study. Clin Chem 2006, 52:2021-2027.
11. Pischon T., Girman C.J., Hotamisligil G.S., et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730-1737.
12. De Caterina R., Zampolli A. From asthma to atherosclerosis-5-lipoxygenase, leukotrienes, and inflammation. N Engl J Med 2004, 350:4-7.
13. Dwyer J.H., Allayee H., Dwyer K.M., et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004, 350:29-37.
14. Inoue N., Kawashima S., Kanazawa K., et al. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998, 97:135-137.
15. Helgadottir A., Manolescu A., Thorleifsson G., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004, 36:233-239.
16. Sutton B.S., Crosslin D.R., Shah S.H., et al. Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets. Hum Mol Genet 2008, 17:1318-1328.
17. Talmud P.J., Bujac S.R., Hall S., Miller G.J., Humphries S.E. Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers. Atherosclerosis 2000, 149:75-81.
18. Humphries S.E., Luong L.A., Ogg M.S., Hawe E., Miller G.J. The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001, 22:2243-2252.
19. Elrayess M.A., Webb K.E., Bellingan G.J., et al. R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD events. Atherosclerosis 2004, 177:127-135.
20. Brull D.J., Leeson C.P., Montgomery H.E., et al. The effect of the Interleukin-6-174G>C promoter gene polymorphism on endothelial function in healthy volunteers. Eur J Clin Invest 2002, 32:153-157.
21. Talmud P.J., Hawe E., Martin S., et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 2002, 11:3039-3046.
22. Helgadottir A., Gretarsdottir S., St Clair D., et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet 2005, 76:505-509.
23. McCullaghPaN J.A. Generalized Linear Models 1989, Chapman and Hall/CRC Press. 2nd ed.
24. Gauderman W.J. Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 2002, 21:35-50.
25. Vaessen S.F., Schaap F.G., Kuivenhoven J.A., et al. Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study. J Lipid Res 2006, 47:2064-2070.
26. Lai C.Q., Demissie S., Cupples L.A., et al. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res 2004, 45:2096-2105.
27. Teslovich T.M., Musunuru K., Smith A.V., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713.
28. Waterworth D.M., Ricketts S.L., Song K., et al. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2010.
29. Palmen J., Smith A.J., Dorfmeister B., et al. The functional interaction on in vitro gene expression of APOA5 SNPs, defining haplotype APOA52, and their paradoxical association with plasma triglyceride but not plasma apoAV levels. Biochim Biophys Acta 2008, 1782:447-452.
30. Talmud P.J., Palmen J., Putt W., Lins L., Humphries S.E. Determination of the functionality of common APOA5 polymorphisms. J Biol Chem 2005, 280:28215-28220.
31. Pennacchio L.A., Olivier M., Hubacek J.A., et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001, 294:169-173.
32. Aouizerat B.E., Kulkarni M., Heilbron D., et al. Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. J Lipid Res 2003, 44:1167-1173.
33. Austin M.A., Talmud P.J., Farin F.M., et al. Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans. Biochim Biophys Acta 2004, 1688:1-9.
34. Jang Y., Kim J.Y., Kim O.Y., et al. The -1131T->C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia, elevated small, dense LDL concentrations, and oxidative stress in nonobese Korean men. Am J Clin Nutr 2004, 80:832-840.
35. Endo K., Yanagi H., Araki J., et al. Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet 2002, 111:570-572.
36. O'Brien P.J., Alborn W.E., Sloan J.H., et al. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem 2005, 51:351-359.
37. Merkel M., Loeffler B., Kluger M., et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem 2005, 280:21553-21560.
38. Dichlberger A., Cogburn L.A., Nimpf J., Schneider W.J. Avian apolipoprotein A-V binds to LDL receptor gene family members. J Lipid Res 2007, 48:1451-1456.
39. Nilsson S.K., Christensen S., Raarup M.K., et al. Endocytosis of apolipoprotein AV by members of the low density lipoprotein receptor and the Vps10p domain receptor families. J Biol Chem 2008.
40. Elosua R., Ordovas J.M., Cupples L.A., et al. Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study. J Lipid Res 2006, 47:990-996.